
Gut Onc Lab
@TheGutOncLab
A collaborative space led by GI medical oncologists to share research, learn together, and highlight what's evolving in GI cancers | #GIonc #OncTwitter
Congrats on the poster and keep up the great work @sidmahajan11 👏
@sidmahajan11 (current resident at @MacNealIMRP and aspiring hematologist/oncologist) at #ASCOQLTY25 presenting his work on the use of minimizing language for adverse event reporting in biliary tract cancer clinical trials 👏 💯 @UGrewalMD @TimothyJBrownMD @GIMedOnc @Deebacca

Was a pleasure to work with @sidmahajan11 on this project. Patients and language around their symptoms matter.
@sidmahajan11 (current resident at @MacNealIMRP and aspiring hematologist/oncologist) at #ASCOQLTY25 presenting his work on the use of minimizing language for adverse event reporting in biliary tract cancer clinical trials 👏 💯 @UGrewalMD @TimothyJBrownMD @GIMedOnc @Deebacca

Biliary tract cancers are tough diseases; they’re rare, mercurial (tissue can be a real challenge), and studies are challenging. Learned a lot working with Matt Gao as he put together this project on premature BTC trial discontinuation for #ASCOQLTY25 Congrats!
We are proud of @IowaMed MS3 Matthew Gao for representing the lab at #ASCOQLTY25 His work is focused on premature discontinuation of biliary tract cancer clinical trials @curecc Manuscript under review 📝 @TimothyJBrownMD @UGrewalMD @Deebacca @GIMedOnc

“Every physician carries within himself a small cemetery, where from time to time he goes to pray.” — René Leriche The guilt is real. Each name finds its place there, quiet and heavy. What surprises me still are the families who meet loss with gratitude—who somehow thank you…
We are proud of @IowaMed MS3 Matthew Gao for representing the lab at #ASCOQLTY25 His work is focused on premature discontinuation of biliary tract cancer clinical trials @curecc Manuscript under review 📝 @TimothyJBrownMD @UGrewalMD @Deebacca @GIMedOnc

Congratulations to our very own Dr Brown on this remarkable achievement! Kudos 💯 @TimothyJBrownMD
Congratulations @TimothyJBrownMD on the Early Stage Research Grant from The Cary Council!

Thank you to the @OncologyTimes for giving me the opportunity to write about my path to oncology and my early career journey at @RoswellPark. I’m truly blessed to be cared about by great mentors and the best squad of friends. @TimothyJBrownMD @Sarbaji85064063 @TheGutOncLab
In this insightful column, Deepak Vadehra, DO, shares what motivated his journey into oncology, and shares advice for new colleagues, saying, "Protect your sense of purpose." Read his article here: ow.ly/s9ak50X6hpu @RoswellPark @Deebacca

Amazing session by @GIMedOnc and @aparna1024 on MSI-H colorectal cancer. So much to learn about this rapidly evolving space. @OncLive @TheGutOncLab

Thankful to my mentor @Sarbaji85064063 for sharing my reflection on my early career journey in oncology. Finding your people in medicine is so important and I’m thankful to have a great friends and mentors to share the journey with. @TimothyJBrownMD @TheGutOncLab @UGrewalMD
Truly enjoyed reading @Deebacca’s reflection in Oncology on purpose and mentorship in oncology. It has been a privilege to witness his journey at @RoswellPark, and it reminded me of the many mentors who shaped my own path and continue to inspire my work today. That spirit of…
ESMO is coming up! Here are the 10 GI studies I'm most excited for! Many more studies; interested in what others are going to be tuning into. @OncoAlert @TheGutOncLab

We are proud to know you and work with you Nick. We will be rooting for you and thanks for all the amazing work that you are doing! 💯👏
🚨 Upcoming Interactive Oncology Event 🚨 Thrilled to join the world-renowned CRC expert Dr. Aparna Parikh @aparna1024 — and me, mostly here to push buttons, advance slides, and try to say something vaguely intelligent — for an Ask the Experts session on Advanced Colorectal…


The homies are back for another lab meeting. Great ideas on early-onset GI cancers. Will we have our first lab paper come out soon? We shall see! See you in 2 weeks 😊💯

Key Neuroendocrine presentations to look out for at ESMO 2025!
Sharing some key Neuroendocrine presentations I’ll be looking for at #ESMO25 (virtually). So excited to see the field moving forward so quickly and kudos to ESMO for making sure rare/uncommon cancers get the spotlight they deserve. 🦓 💯 👏

Latest from my alma mater @uiowacancer — led by Jeremy Chang, Jim Howe et al: Peritoneal metastases occur in ~30% of small bowel NETs. N=396 patients 🔹 Risk factors: liver mets, female sex, higher T stage, ↑ pancreastatin 🔹 PM → worse OS (109 vs 169 mo) & PFS (42 vs 75 mo)…

🚨 New post-hoc analysis from #SUNLIGHT trial in refractory #mCRC: Severe neutropenia linked to better OS (HR 0.37) & PFS (HR 0.41). Lonsurf+ bevacizumab improved survival regardless of neutropenia status. Toxicity as a biomarker? 👀 I’m still in the every other week ⛺️!…
Must read by a powerhouse trio. @TimothyJBrownMD @UGrewalMD @NiuSanford @TheGutOncLab
Treat the Tumor, Spare the Esophagus: The Case for Organ Preservation in Locally Advanced Esophageal/Gastroesophageal Junction Cancer. Co-authored by @UGrewalMD, @NiuSanford, and @TimothyJBrownMD. Read the full article. brnw.ch/21wVVPG #esocsm
An aspirin a day keeps the medical oncologist away? ALASCCA made waves at GI ASCO 🌊 when it showed that a cheap, widely available drug—low-dose aspirin—can meaningfully reduce recurrence risk in a genomically selected subset of colorectal cancer. This randomized,…
Very excited for this upcoming webinar with @NCFCancer @lisayentwin on Alpha Radioligand Therapy and other things PRRT next week. Looking forward to interacting with patients and caregivers and answering questions regarding RLT and more. Link to register-…

Thank you for presenting and representing at #ESMOGI! Excited to be able to work with you further with the @TheGutOncLab!
“Treat the Tumor, Spare the Esophagus: The Case for Organ Preservation in Locally Advanced Esophageal/Gastroesophageal Junction Cancer” Out now in @JCO_ASCO. Great work led by @UGrewalMD and joined by @NiuSanford ascopubs.org/doi/10.1200/JC…
United States الاتجاهات
- 1. Auburn 46.1K posts
- 2. At GiveRep N/A
- 3. Brewers 65.7K posts
- 4. Cubs 56.8K posts
- 5. #SEVENTEEN_NEW_IN_TACOMA 33.8K posts
- 6. Georgia 68.6K posts
- 7. Gilligan 6,225 posts
- 8. #byucpl N/A
- 9. MACROHARD 4,869 posts
- 10. Utah 25.2K posts
- 11. Arizona 42.1K posts
- 12. Kirby 24.4K posts
- 13. Wordle 1,576 X N/A
- 14. #AcexRedbull 4,274 posts
- 15. Michigan 62.5K posts
- 16. #SVT_TOUR_NEW_ 25.5K posts
- 17. Boots 51.4K posts
- 18. #Toonami 2,998 posts
- 19. mingyu 91.4K posts
- 20. Hugh Freeze 3,284 posts
Something went wrong.
Something went wrong.